Live news related to ADOCIA stock (FR0011184241): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
Biopharmaceutical company Adocia has announced the signing of a current account advance agreement with Vester Finance, for a total amount of 6 million…
Adocia announced the completion of the Phase 3 program for BioChaperone® Lispro with its Chinese partner Tonghua Dongbao, showing positive results in …
The Lyon-based biopharmaceutical company Adocia has announced the dates for its financial publications and general assembly for the fiscal year 2026.
Lyon-based biopharmaceutical company Adocia has announced the publication dates for its financial and operational indicators for the year 2026, accord…
Biopharmaceutical company Adocia announces the filing of a patent for its AdoXLong platform, aimed at extending the action of peptides to one month.
Adocia has released its financial results for the third quarter of 2025 and reported clinical progress on its ultra-rapid BioChaperone® Lispro insulin…
Adocia and its partner Tonghua Dongbao have announced positive results from a Phase 3 clinical trial of BioChaperone® Lispro, an ultra-rapid insulin, …
The Lyon-based company specializing in diabetes and obesity treatments experienced a particularly dynamic week, closing at €9.75 on Friday, October 10…
